CROSS CTRY HEALTHCARE INC's ticker is CCRN and the CUSIP is 227483104. A total of 117 filers reported holding CROSS CTRY HEALTHCARE INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $995,470 | -22.4% | 71,927 | +4.9% | 0.01% | -33.3% |
Q1 2024 | $1,283,649 | -17.3% | 68,571 | 0.0% | 0.01% | -25.0% |
Q4 2023 | $1,552,447 | +50.5% | 68,571 | +64.8% | 0.01% | +71.4% |
Q3 2023 | $1,031,190 | -39.4% | 41,597 | -31.4% | 0.01% | -41.7% |
Q2 2023 | $1,701,451 | +22.3% | 60,593 | -2.8% | 0.01% | +20.0% |
Q1 2023 | $1,390,848 | -18.8% | 62,314 | -3.3% | 0.01% | -23.1% |
Q4 2022 | $1,712,622 | +90562.9% | 64,457 | -3.2% | 0.01% | -18.8% |
Q3 2022 | $1,889 | -99.9% | 66,575 | +0.6% | 0.02% | +33.3% |
Q2 2022 | $1,378,000 | -3.9% | 66,156 | 0.0% | 0.01% | +33.3% |
Q1 2022 | $1,434,000 | -28.2% | 66,156 | -8.1% | 0.01% | -18.2% |
Q4 2021 | $1,998,000 | +31.4% | 71,986 | +0.6% | 0.01% | +22.2% |
Q3 2021 | $1,520,000 | +28.6% | 71,586 | 0.0% | 0.01% | +28.6% |
Q2 2021 | $1,182,000 | +31.3% | 71,586 | -0.6% | 0.01% | +16.7% |
Q1 2021 | $900,000 | +31.2% | 72,026 | -6.9% | 0.01% | +20.0% |
Q4 2020 | $686,000 | +4.3% | 77,346 | -23.7% | 0.01% | 0.0% |
Q3 2020 | $658,000 | +29.5% | 101,414 | +23.0% | 0.01% | 0.0% |
Q2 2020 | $508,000 | -8.6% | 82,436 | 0.0% | 0.01% | -16.7% |
Q1 2020 | $556,000 | -42.0% | 82,436 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $958,000 | -1.1% | 82,436 | -12.3% | 0.01% | 0.0% |
Q3 2019 | $969,000 | +33.8% | 94,036 | +21.8% | 0.01% | 0.0% |
Q2 2019 | $724,000 | +223.2% | 77,236 | +142.6% | 0.01% | +200.0% |
Q1 2019 | $224,000 | -3.9% | 31,836 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $233,000 | +6.4% | 31,836 | +26.7% | 0.00% | 0.0% |
Q3 2018 | $219,000 | -15.4% | 25,136 | +9.3% | 0.00% | 0.0% |
Q2 2018 | $259,000 | +1.2% | 23,002 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $256,000 | -12.9% | 23,002 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $294,000 | -10.1% | 23,002 | 0.0% | 0.00% | +100.0% |
Q3 2017 | $327,000 | +49.3% | 23,002 | +35.5% | 0.00% | -50.0% |
Q2 2017 | $219,000 | -31.6% | 16,973 | -23.8% | 0.00% | -33.3% |
Q1 2017 | $320,000 | -8.0% | 22,273 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $348,000 | +32.8% | 22,273 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $262,000 | -15.5% | 22,273 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $310,000 | +19.7% | 22,273 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $259,000 | -29.0% | 22,273 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $365,000 | -24.4% | 22,273 | -37.2% | 0.00% | -25.0% |
Q3 2015 | $483,000 | -18.0% | 35,473 | -23.7% | 0.00% | 0.0% |
Q2 2015 | $589,000 | -10.5% | 46,473 | -16.2% | 0.00% | -20.0% |
Q1 2015 | $658,000 | -4.2% | 55,473 | +0.7% | 0.01% | +25.0% |
Q4 2014 | $687,000 | +34.2% | 55,073 | 0.0% | 0.00% | +33.3% |
Q3 2014 | $512,000 | +32.3% | 55,073 | -7.2% | 0.00% | +50.0% |
Q2 2014 | $387,000 | -12.2% | 59,373 | +8.8% | 0.00% | -33.3% |
Q1 2014 | $441,000 | -33.0% | 54,589 | -17.2% | 0.00% | -25.0% |
Q4 2013 | $658,000 | +67.0% | 65,889 | +1.4% | 0.00% | +100.0% |
Q3 2013 | $394,000 | +36.3% | 64,989 | +15.9% | 0.00% | 0.0% |
Q2 2013 | $289,000 | – | 56,089 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Simcoe Capital Management, LLC | 1,143,625 | $23,822,000 | 3.28% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 2,194,340 | $45,708,000 | 1.59% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 704,526 | $14,676,000 | 1.51% |
Mesirow Financial Investment Management, Inc. | 12,643 | $263,000 | 1.27% |
Aristotle Capital Boston, LLC | 1,638,612 | $34,132,000 | 1.02% |
Zebra Capital Management LLC | 14,351 | $299,000 | 0.88% |
Alpha DNA Investment Management LLC | 49,398 | $1,028,000 | 0.88% |
SummerHaven Investment Management, LLC | 55,577 | $1,158,000 | 0.78% |
GLOBEFLEX CAPITAL L P | 145,700 | $3,035,000 | 0.74% |
OBERWEIS ASSET MANAGEMENT INC/ | 96,900 | $2,018,000 | 0.51% |